The prognostic value of tumor-informed minimal residual disease detection using circulating tumor DNA in first-line treatment of ovarian cancer.
Shu T, Liang Y, Zhang S, Sun T, Gao Y, Guo C, Li Z, Gao M, Zhang N, Song N, Zhang N, Gao W, Wang W, Wang H, Cai Y, Zhang F, Ji X, Dong Y, Zheng H.
Shu T, et al. Among authors: song n.
Gynecol Oncol. 2024 Nov 22;192:94-101. doi: 10.1016/j.ygyno.2024.11.002. Online ahead of print.
Gynecol Oncol. 2024.
PMID: 39579602